Literature DB >> 30668794

Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2.

Jan Willem Cohen Tervaert1.   

Abstract

Entities:  

Year:  2019        PMID： 30668794     DOI： 10.1093/ndt/gfy406

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

Review 1.  Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis.

Authors:  Mohammed S Osman; Jan Willem Cohen Tervaert
Journal:  Curr Rheumatol Rep       Date:  2019-12-26       Impact factor: 4.592

2.  The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis.

Authors:  Aleksandra Rymarz; Magdalena Mosakowska; Stanisław Niemczyk
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis.

Authors:  Kristen M Gibson; Renate Kain; Raashid A Luqmani; Colin J Ross; David A Cabral; Kelly L Brown
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.